EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non–muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019

Francesco Montorsi, Marco Moschini, Andrea Salonia, Giorgio Gandaglia, Alberto Briganti

European Urology Focus · 2024

DOI: 10.1016/j.euf.2023.12.007 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Urology Focus, 2024. Verfasst von Francesco Montorsi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, BCG Vaccine, Cystectomy. Die Arbeit nennt 1 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsBCG VaccineCystectomyHumansFeasibility StudiesRandomized Controlled Trials as TopicAdjuvants, ImmunologicNeoplasm InvasivenessCombined Modality TherapyAdministration, IntravesicalReoperationNon-Muscle Invasive Bladder Neoplasms

Substanzen

BCG VaccineAdjuvants, Immunologic

Autor:innen und Institutionen

  • Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: marco.moschini87@gmail.com.

Zitieren

APA

Montorsi, F., Moschini, M., Salonia, A., Gandaglia, G., & Briganti, A. (2024). Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non–muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019. European Urology Focus. https://doi.org/10.1016/j.euf.2023.12.007

Vancouver

Montorsi F, Moschini M, Salonia A, Gandaglia G, Briganti A. Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non–muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019. European Urology Focus. 2024. doi:10.1016/j.euf.2023.12.007

BibTeX
@article{Montorsi2024,
  author = {Montorsi, Francesco and Moschini, Marco and Salonia, Andrea and Gandaglia, Giorgio and Briganti, Alberto},
  title = {Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non–muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019},
  journal = {European Urology Focus},
  year = {2024},
  doi = {10.1016/j.euf.2023.12.007}
}
Kostenlos starten →